# Ensysce Biosciences, Inc.: Form 8-K, filed Oct 18, 2024

- Company: [Ensysce Biosciences, Inc.](/companies/ensc.md) (CIK 1716947)
- Form: 8-K
- Filed: 2024-10-18
- Accepted by EDGAR: Oct 18, 2024, 16:56 ET
- Period: 2024-10-18
- Accession: 0001493152-24-041589
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1716947/000149315224041589/form8-k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1716947/000149315224041589/

## Items reported

- Item 5.03: Amendment to articles or bylaws
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1716947/000149315224041589/form8-k.htm

Filed Oct 18, 2024.
Source: SEC EDGAR, the filing index for accession 0001493152-24-041589. Last ingested by Listed: Nov 4, 2026, 12:47 ET. No prices; not investment advice.